糖尿病對話卡與團體衛教介入對第二型糖尿病注射基礎型胰島素病人血糖控制成效之探討

Diabetes Education Intervention for Type 2 Diabetic Patient with Basal Insulin Therapy

10.3966/168232812017062702001

林育姿(Yu-Tze Lin)；黃建寧(Chien-Ning Huang)；王威傑(Edy Kornelius)；李靜茹(Ching-Lu Li)；吳月珠(Yueh-Chu Wu)；蕭惠文(Hui-Wen Hsaio)；楊宜瑱(Yi-Sun Yang)

糖尿病衛教 ； 第二型糖尿病 ； 基礎型胰島素 ； 血糖控制 ； basal insulin ； diabetes education ； glucose control ； type 2 diabetes

台灣家庭醫學雜誌

27卷2期（2017 / 06 / 01）

65 - 76

繁體中文

目的：本研究旨在探討注射基礎型胰島素之第二型糖尿病病人以積極的衛教介入三個月之照護品質成效。方法：採介入性研究設計，共收集取樣150位糖尿病病人，分配糖尿病對話卡組和一般常規衛教組，糖尿病對話卡組須參加至少一次糖尿病對話卡團體衛教和三個月的電訪追蹤，一般常規衛教組僅一般常規回診時衛教室追蹤，為期一年的追蹤來評估兩組介入前後身體質量指數、血壓、糖化血色素、空腹血糖、血清肌酸酐和低血糖頻率等變化。結果：比較兩組各75人在追蹤三個月和追蹤十二個月其糖化血色素皆有改善，以ANCOVA分析兩組呈現統計上顯著差異(p＜0.05)，但身體質量指數和血壓皆無統計上顯著差異。另外，比較兩組於追蹤一年期間皆持續施打基礎型胰島素合併口服降血糖藥物的病人時，兩組各43人在追蹤三個月時糖化血色素有統計上顯著差異(p＜0.05)，但追蹤十二個月卻無顯著差異。結論：糖尿病病人無論是團體衛教或是一般衛教都有助於降低糖化血色素，團體衛教積極介入效果更是顯著，建議未來針對胰島素注射病人宜強調衛教課程和電訪的介入，以讓糖尿病照護更有效益。

Background: This study was designed to investigate the effectiveness of implementing a structured education for the patients who started on basal insulin. Methods: A total of 150 participants were enrolled for this study and allocated into either an intervention or a control group. Participants in the intervention group were required to attend at least one diabetes group education session using interactive dialogue cards; those in the control group received usual care provided at an outpatient clinic. Body mass index, blood pressure, glycated hemoglobin (HbA1c), fasting blood glucose, serum creatinine, self-monitoring blood glucose frequency were evaluated before and after intervention at 3, 6 and 12 months. Results: Compared to their counterparts in the control group, participants in the intervention group reported a greater reduction in HbA1c level. There was a greater proportion of patients receiving intensification of insulin therapy in the intervention group. No difference, however, was observed between the two groups in terms of changes in body mass index and blood pressure. Conclusion: Results of the study indicate that interactive group education helps patients who just start receiving insulin therapy strengthen glycemic control. Interventions in the forms of group education and telephone follow-up should therefore be provided for patients with basal insulin therapy.

1. 衛生福利部：102年度死因統計。引用2014年9月4日，取自http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=5150
2. Steno Diabetes Center of Danmark, education to action. https://steno.dk/. Accessed December 2, 2014.
3. American Diabetes Association(2014).Standards of medical care in diabetes.Diabetes Care,37,14-80.
4. Andersom, RM,Hiss, RG,Stepien, CJ(1994).The diabetes education experience of randomly selected patients under the care of community physicians.Diabetes Educator,20,399-405.
5. Anderson, RM,Funnell, MM,Aikens, JE(2009).Evaluating the efficacy of an Empowerment- based self-management consultant intervention: Results of a two-year randomised controlled trial.The Patient Educ,1,3-11.
6. Ang, Y,Ng, TK,Chong, CN,Ch'ng, KH(2014).Diabetes and weight loss: a pilot study.Clin Health Promot,4,61-2.
7. Beeney, LJ,Dunn, SM(1990).Knowledge improvement and metabolic control in diabetes education: approaching the limits?.Patient Educ Couns,16,217-29.
8. Brown, SA(1990).Studies of education interventions and outcomes in diabetic adults: a metaanalysis revisited.Patient Educ Couns,16,189-215.
9. Choe, HM,Mitrovich, S,Dubay, D,Hayward, RA,Krein, SL,Vijan, S(2005).Proactive case management of high risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial.AmJ Manag Care,11,253-60.
10. Chuang, LM,Lin, BJ,Wu, TJ,Chen, YH,Tai, TY(1989).The effect of health education for diabetics in the community.J Formosan Med Assoc,88,1143-6.
11. Clifford, RM,Davis, WA,Batty, KT,Davis, TM(2005).Fremantle Diabetes Study: Effect of a pharmaceutical care program on vascular risk factors in Type 2 diabetes: the Fremantle diabetes study.Diabetes Care,28,771-6.
12. Dijkstra, RF,Braspenning, JCC,Huijsmans, Z,Akkermans, RP(2005).Introduction of diabetes passports involving both patients and professionals to improve hospital outpatient diabetes care.Diabetes Res Clin Pract,68,126-34.
13. Early Treatment Diabetic Retinopathy Study Research Group(1991).Early photocoagulation for diabetic retinopathy: ETDRS report number 9.Ophthalmology,98,766-85.
14. Haas, L,Maryniuk, M,Beck, J(2014).National standards for diabetes self-management education and support.Diabetes Care,37(Suppl 1),S144-53.
15. Hoskins, PL,Fowler, PM,Constantino, M,Forrest, J,Yue, DK,Turtle, JR(1993).Sharing the care of diabetic patients between hospital and general practitioners: does it work?.Diabet Med,10,81-6.
16. Ilag, LL,Martin, CL,Tabaei, BP(2003).Improving diabetes processes of care in managed care.Diabetes Care,26,2722-7.
17. Litzelman, DK,Slemenda, CW,Langefeld, CD(1993).Reduction of lower extremity clinical abnormalities in patients with non-insulin dependent diabetes mellitus.Ann Intern Med,119,36-41.
18. Martin, CL,Albers, J,Herman, WH(2006).DCCT/EDIC Research Group: Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.Diabetes Care,29,340-4.
19. Miller, KM,Beck, RW,Bergenstal, RM(2013).T1D Exchange Clinic Network. Evidence of a strong association between frequency of selfmonitoring of blood glucose and hemoglobin A1c levels in T1D Exchange clinic registry participants.Diabetes Care,36,2009-14.
20. Muller, N,Kloos, C,Samann, A,Wolf, G,Muller, UA(2013).Evaluation of a treatment and teaching refresher programme for the optimization of intensified insulin therapy in type 1 diabetes.Patient Educ Couns,93,108-13.
21. Prescott, G,Sharp, P,Goatman, K(2014).Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK study.Br J Ophthalmol,98,1042-9.
22. Pyorala, K,Pedersen, TR,Kjekshus, J,Faergeman, O,Olsson, AG,Thorgiersson, G(1997).Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).Diabetes Care,20,614-20.
23. Riddle, MC,Rosenstock, J,Gerich, J(2003).Insulin Glargine 4002 Study Investigators: The treatto-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.Diabetes Care,26,3080-6.
24. Rith-Najarian, SJ,Stolusky, T,Gohdes, DM(1992).Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting: a prospective evaluation of simple screening criteria.Diabetes Care,15,1386-9.
25. Rodby, RA,Firth, LM,Lewis, EF(1996).The Collaborative Study Group: an economic analysis of captopril in the treatment of diabetic nephropathy.Diabetes Care,19,1051-61.
26. Shojania, KG,Ranji, SR,McDonald, KM(2006).Effects of quality improvement strategies for type 2 diabetes on glycemic control: a metaregression analysis.JAMA,296,427-40.
27. Spallone, V,Ziegler, D,Freeman, R(2011).Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.Diabetes Metab Res Rev,27,639-53.
28. Stratton, 1M,Adler, AI,Neil, HA(2000).Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.BMJ,321,405-12.
29. The Diabetes Control and Complications Trial Research Group(1993).The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med,329,977-86.
30. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group(2000).Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.N Engl J Med,342,381-9.
31. UK Prospective Diabetes Study (UKPDS) Group(1998).Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).Lancet,352,854-86.
32. UK Prospective Diabetes Study (UKPDS) Group(1998).Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet,352,837-53.
33. Wing, RR,Epstein, LH,Paternostro-Bayles, M,Kriska, A,Nowalk, MP,Gooding, W(1988).Exercise in a behavioural weight control programme for obese patients with Type 2 (non-insulindependent) diabetes.Diabetologia,31,902-9.
34. Yki-Järvinen, H,Juurinen, L,Alvarsson, M(2007).Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.Diabetes Care,30,1364-9.